Jazan Endocrinology & Diabetes Center, Ministry of Health, Jazan 45142, Saudi Arabia.
Faculty of Medicine and Health Sciences, Taiz University, Taiz P.O. Box 6803, Yemen.
Int J Environ Res Public Health. 2022 Dec 14;19(24):16794. doi: 10.3390/ijerph192416794.
Saudi Arabia is a country with high prevalence of diabetes, uncontrolled diabetes, and diabetes-related complications. Poor glycemic control is multifactorial and could be explained in part by physician and patient reluctance toward insulin or insulin inertia. This study aimed to address physician barriers toward insulin therapy in primary care settings. It included 288 physicians from 168 primary healthcare centers (PHC) in the Jazan region of Saudi Arabia. Participants responded to questionnaire investigating physicians' attitude and barriers to insulin initiation and intensification in PHCs. In physician opinion, the most common barriers among their patients were fear of injection, lack of patient education, fear of hypoglycemia, and difficult administration. Physicians were reluctant to initiate insulin for T2D patients mostly due to patient non-adherence to blood sugar measurement, non-adherence to appointment or treatment, elderly patients, or due to patient refusal. Physicians' fear of hypoglycemia, lack of staff for patient education, and lack of updated knowledge were the primary clinician-related barriers. Exaggerated fears of insulin side effects, patient non-adherence, limited staff for patient's education, patient refusal, and inadequate consultation time were the main barriers to insulin acceptance and prescription.
沙特阿拉伯是一个糖尿病、未控制的糖尿病和糖尿病相关并发症患病率较高的国家。血糖控制不佳是多因素的,部分原因可能是医生和患者不愿意使用胰岛素或存在胰岛素惰性。本研究旨在解决初级保健环境中医生对胰岛素治疗的障碍。它包括来自沙特阿拉伯吉赞地区 168 个初级保健中心的 288 名医生。参与者回答了一份调查问卷,调查了医生在初级保健中心启动和强化胰岛素治疗的态度和障碍。在医生看来,患者最常见的障碍是害怕注射、缺乏患者教育、害怕低血糖和给药困难。医生不愿意为 T2D 患者启动胰岛素治疗,主要是因为患者不遵守血糖测量、不遵守预约或治疗、老年患者,或因为患者拒绝。医生对低血糖的恐惧、缺乏对患者进行教育的人员以及缺乏最新知识是与临床医生相关的主要障碍。对胰岛素副作用的过度恐惧、患者不遵医嘱、患者教育人员有限、患者拒绝和咨询时间不足是接受和开具胰岛素处方的主要障碍。